Logo

Pathwork Diagnostics Gets CAP Accreditation

Mar 29, 2011

By a GenomeWeb Staff Reporter

NEW YORK (GenomeWeb News) – Pathwork Diagnostics today said that it has received accreditation from the College of American Pathologists.

Patthwork Diagnostics offers its Tissue of Origin test through its CLIA lab. The test measures the gene expression levels of more than 2,000 genes to help identify the origin of metastatic and poorly differentiated tumors.

Last year, the firm received US Food and Drug Administration clearance for the test.

Filed under

Molecular Diagnostics
Regulatory News & FDA Approvals
Microarrays & Multiplexing
Diagnostics
Cancer
CAP
microarrays
Pathwork Diagnostics
Breaking News
The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.